NELSON: the Trafalgar of lung cancer screening?
Symposium Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), M. Revel (Paris, France)
Aims: to present NELSON results 1 year after the first data were released, consensus data on participant selection and consensus data on nodule handling to minimise the false positive rate; to discuss the cost-effectiveness of lung cancer screening; to address the ethical dilemma of screening current smokers.